Guarini Kathryn 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Sep 12, 2023
Insider Transaction Report
Form 4
Guarini Kathryn
Director
Transactions
- Award
Common Stock
2023-09-08+240→ 240 total - Award
Non-Qualified Stock Option (right to buy)
2023-09-08+2,739→ 2,739 totalExercise: $833.23Exp: 2033-09-08→ Common Stock (2,739 underlying)
Footnotes (2)
- [F1]Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
- [F2]On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.